Published in Mol Cell Biol on January 01, 1993
Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways. EMBO J (1993) 4.35
The downstream core promoter element, DPE, is conserved from Drosophila to humans and is recognized by TAFII60 of Drosophila. Genes Dev (1997) 4.25
Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J (1997) 3.34
Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci U S A (1995) 2.92
Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates. Mol Cell Biol (1999) 2.80
Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res (1995) 2.33
Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucleic Acids Res (1997) 2.24
The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds. Mol Cell Biol (1993) 2.06
Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc Natl Acad Sci U S A (1994) 1.98
Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation. Mol Cell Biol (1994) 1.98
Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission. Proc Natl Acad Sci U S A (1995) 1.89
Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol Cell Biol (1994) 1.74
Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation. EMBO J (1998) 1.71
The signalling pathways of interleukin-6 and gamma interferon converge by the activation of different transcription factors which bind to common responsive DNA elements. Mol Cell Biol (1994) 1.70
Convergence of TNFalpha and IFNgamma signalling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS/kappaB promoter element. Nucleic Acids Res (1997) 1.50
STF-IL-4: a novel IL-4-induced signal transducing factor. EMBO J (1994) 1.46
NFAT regulates the expression of AIF-1 and IRT-1: yin and yang splice variants of neointima formation and atherosclerosis. Cardiovasc Res (2011) 1.42
Restoration of interferon responses of adenovirus E1A-expressing HT1080 cell lines by overexpression of p48 protein. J Virol (1997) 1.36
p300 forms a stable, template-committed complex with chromatin: role for the bromodomain. Mol Cell Biol (2001) 1.34
p38 MAPK enhances STAT1-dependent transcription independently of Ser-727 phosphorylation. Proc Natl Acad Sci U S A (2002) 1.30
Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes. Nucleic Acids Res (1993) 1.21
A unique palindromic element mediates gamma interferon induction of mig gene expression. Mol Cell Biol (1994) 1.19
cIRF-3, a new member of the interferon regulatory factor (IRF) family that is rapidly and transiently induced by dsRNA. Nucleic Acids Res (1995) 1.18
The DNA damage response induces IFN. J Immunol (2011) 1.13
The response of gamma interferon activation factor is under developmental control in cells of the macrophage lineage. Mol Cell Biol (1993) 1.11
Design of conditionally active STATs: insights into STAT activation and gene regulatory function. Mol Cell Biol (1999) 1.11
Receptor to nucleus signaling by prolactin and interleukin 2 via activation of latent DNA-binding factors. Proc Natl Acad Sci U S A (1994) 1.09
Interferon gamma-induced transcription of the murine ISGF3gamma (p48) gene is mediated by novel factors. Proc Natl Acad Sci U S A (1997) 1.08
Antiviral and immunoregulatory activities of IFN-gamma depend on constitutively expressed IL-1alpha. Proc Natl Acad Sci U S A (2007) 1.08
The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. Mol Cell Biol (1996) 1.07
Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma-dependent cyclooxygenase 2 expression. J Exp Med (2000) 1.04
Prolactin activates the interferon-regulated p91 transcription factor and the Jak2 kinase by tyrosine phosphorylation. Proc Natl Acad Sci U S A (1994) 1.03
5' upstream sequences of MyD88, an IL-6 primary response gene in M1 cells: detection of functional IRF-1 and Stat factors binding sites. Nucleic Acids Res (1995) 0.99
Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes. Proc Natl Acad Sci U S A (1995) 0.98
Regulation of Stat1 protein expression by phenylalanine 172 in the coiled-coil domain. Biochem Biophys Res Commun (2006) 0.98
Leishmania major infection activates NF-kappaB and interferon regulatory factors 1 and 8 in human dendritic cells. Infect Immun (2008) 0.94
Constitutive nuclear factor kappaB activity is required to elicit interferon-gamma-induced expression of chemokine CXC ligand 9 (CXCL9) and CXCL10 in human tumour cell lines. Biochem J (2003) 0.92
In vivo footprinting of the IRF-1 promoter: inducible occupation of a GAS element next to a persistent structural alteration of the DNA. Nucleic Acids Res (1994) 0.91
Inhibition of cytokine-induced JAK-STAT signalling pathways by an endonuclease inhibitor aurintricarboxylic acid. Br J Pharmacol (2002) 0.88
Characterization of the 5'-flanking region and regulation of expression of human anion exchanger SLC26A6. J Cell Biochem (2008) 0.86
Chicken interferon consensus sequence-binding protein (ICSBP) and interferon regulatory factor (IRF) 1 genes reveal evolutionary conservation in the IRF gene family. Proc Natl Acad Sci U S A (1995) 0.86
Suppression of growth by all-trans retinoic acid requires prolonged induction of interferon regulatory factor 1 in cervical squamous carcinoma (SiHa) cells. Clin Diagn Lab Immunol (2002) 0.84
STAT1 as a central mediator of IFNγ and TLR4 signal integration in vascular dysfunction. JAKSTAT (2012) 0.84
Helicobacter pylori disrupts STAT1-mediated gamma interferon-induced signal transduction in epithelial cells. Infect Immun (2004) 0.83
The immune response modifier imiquimod requires STAT-1 for induction of interferon, interferon-stimulated genes, and interleukin-6. Antimicrob Agents Chemother (1999) 0.82
Growth arrest of epithelial cells during measles virus infection is caused by upregulation of interferon regulatory factor 1. J Virol (2004) 0.81
Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells. Mol Cell Biol (1998) 0.81
GAAP-1: a transcriptional activator of p53 and IRF-1 possesses pro-apoptotic activity. EMBO Rep (2002) 0.81
Oncogenicity of human papillomavirus- or adenovirus-transformed cells correlates with resistance to lysis by natural killer cells. J Virol (1995) 0.78
The benzoxathiolone LYR-71 down-regulates interferon-gamma-inducible pro-inflammatory genes by uncoupling tyrosine phosphorylation of STAT-1 in macrophages. Br J Pharmacol (2009) 0.77
Mechanisms of resistance to interferon-gamma-mediated cell growth arrest in human oral squamous carcinoma cells. J Biol Chem (2009) 0.76
Ligand-dependent and -independent activation of the transcription factor gamma RF-1 in a cell-free system. Biochem J (1995) 0.76
DNA plasticity is a key determinant of the energetics of binding of Jun-Fos heterodimeric transcription factor to genetic variants of TGACGTCA motif. Biochemistry (2009) 0.76
HIV-1 Tat Recruits HDM2 E3 Ligase To Target IRF-1 for Ubiquitination and Proteasomal Degradation. MBio (2016) 0.75
Maximal Expression of the Evolutionarily Conserved Slit2 Gene Promoter Requires Sp1. Cell Mol Neurobiol (2015) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res (1984) 181.98
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30
A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell (1986) 36.96
CpG-rich islands and the function of DNA methylation. Nature (1986) 24.90
CpG islands in vertebrate genomes. J Mol Biol (1987) 23.16
Control of eukaryotic messenger RNA synthesis by sequence-specific DNA-binding proteins. Nature (1985) 14.41
Using mini-prep plasmid DNA for sequencing double stranded templates with Sequenase. Biotechniques (1988) 10.14
Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell (1988) 9.04
The inducible transcription activator NF-kappa B: regulation by distinct protein subunits. Biochim Biophys Acta (1991) 7.70
Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques (1988) 6.83
Multiple specific contacts between a mammalian transcription factor and its cognate promoters. Nature (1985) 6.77
Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell (1989) 6.11
Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Dev (1988) 6.08
A high-efficiency HeLa cell nuclear transcription extract. DNA (1988) 5.81
The human beta-interferon gene enhancer is under negative control. Cell (1986) 5.61
The involvement of NF-kappa B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell (1989) 5.50
Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro. Genes Dev (1989) 5.09
Construction of plasmids that express E. coli beta-galactosidase in mammalian cells. Nucleic Acids Res (1989) 5.02
Double-stranded RNA activates binding of NF-kappa B to an inducible element in the human beta-interferon promoter. EMBO J (1989) 4.10
Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell (1990) 3.58
Delimitation and properties of DNA sequences required for the regulated expression of human interferon-beta gene. Cell (1985) 3.57
Overlapping positive and negative regulatory domains of the human beta-interferon gene. Proc Natl Acad Sci U S A (1988) 3.54
An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci U S A (1990) 3.53
Interferon-beta gene regulation: tandemly repeated sequences of a synthetic 6 bp oligomer function as a virus-inducible enhancer. Cell (1987) 3.51
Detection of factors that interact with the human beta-interferon regulatory region in vivo by DNAase I footprinting. Cell (1986) 3.35
A single DNA response element can confer inducibility by both alpha- and gamma-interferons. Proc Natl Acad Sci U S A (1989) 3.33
Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon- and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol Cell Biol (1990) 3.31
Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor. EMBO J (1991) 3.28
A DNA-binding protein containing two widely separated zinc finger motifs that recognize the same DNA sequence. Genes Dev (1990) 3.26
Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature (1989) 3.25
Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements. EMBO J (1988) 3.11
DNA binding of purified transcription factor NF-kappa B. Affinity, specificity, Zn2+ dependence, and differential half-site recognition. J Biol Chem (1991) 2.80
Rapid activation by interferon alpha of a latent DNA-binding protein present in the cytoplasm of untreated cells. Proc Natl Acad Sci U S A (1989) 2.74
Two interferon-induced nuclear factors bind a single promoter element in interferon-stimulated genes. Proc Natl Acad Sci U S A (1988) 2.58
Multiple determinants of eukaryotic mRNA stability. New Biol (1989) 2.52
Two different virus-inducible elements are required for human beta-interferon gene regulation. EMBO J (1989) 2.50
Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proc Natl Acad Sci U S A (1989) 2.38
Critical role of a common transcription factor, IRF-1, in the regulation of IFN-beta and IFN-inducible genes. EMBO J (1992) 2.34
Sequence of a cDNA coding for human IRF-1. Nucleic Acids Res (1989) 2.01
Involvement of a cis-element that binds an H2TF-1/NF kappa B like factor(s) in the virus-induced interferon-beta gene expression. Nucleic Acids Res (1989) 1.97
Cell poration and cell fusion using an oscillating electric field. Biophys J (1989) 1.92
Different pathways mediate virus inducibility of the human IFN-alpha 1 and IFN-beta genes. Cell (1990) 1.91
Induction of human interferon gene expression is associated with a nuclear factor that interacts with the NF-kappa B site of the human immunodeficiency virus enhancer. J Virol (1989) 1.90
Overlapping sites for constitutive and induced DNA binding factors involved in interferon-stimulated transcription. EMBO J (1989) 1.87
Reversible silencing of enhancers by sequences derived from the human IFN-alpha promoter. Cell (1987) 1.87
The interferon genes. Prog Nucleic Acid Res Mol Biol (1986) 1.85
A gamma-interferon-induced factor that binds the interferon response sequence of the MHC class I gene, H-2Kb. EMBO J (1989) 1.78
B-cell-specific and interferon-gamma-inducible regulation of the HLA-DR alpha gene. Proc Natl Acad Sci U S A (1988) 1.70
Synergism between distinct enhanson domains in viral induction of the human beta interferon gene. Mol Cell Biol (1990) 1.46
Detailed delineation of an interferon-gamma-responsive element important in human HLA-DRA gene expression in a glioblastoma multiform line. Proc Natl Acad Sci U S A (1988) 1.46
Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: role in growth inhibition. Cell Growth Differ (1991) 1.43
Regulation of synthesis and turnover of an interferon-inducible mRNA. Mol Cell Biol (1986) 1.43
Transcription factors induced by interferons alpha and gamma. Nucleic Acids Res (1990) 1.37
Interferon-regulatory factor 1 is an immediate-early gene under transcriptional regulation by prolactin in Nb2 T cells. Mol Cell Biol (1990) 1.33
Multimerization of AAGTGA and GAAAGT generates sequences that mediate virus inducibility by mimicking an interferon promoter element. Proc Natl Acad Sci U S A (1991) 1.23
The control of interferon-inducible gene expression. FEBS Lett (1991) 1.19
The regulation of beta-interferon gene expression. Semin Cancer Biol (1990) 1.06
High efficiency gene transfection by electroporation using a radio-frequency electric field. Biochim Biophys Acta (1991) 0.97
Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol (1995) 2.62
Trichloroethene reductive dehalogenase from Dehalococcoides ethenogenes: sequence of tceA and substrate range characterization. Appl Environ Microbiol (2000) 2.34
Amylase normal, lipase elevated: is it pancreatitis? A case series and review of the literature. Am J Gastroenterol (1999) 2.10
Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood (1992) 2.00
Global transcriptome analysis of Shewanella oneidensis MR-1 exposed to different terminal electron acceptors. J Bacteriol (2005) 1.97
Isolation and sequencing of a cDNA clone encoding lysosomal membrane glycoprotein mouse LAMP-1. Sequence similarity to proteins bearing onco-differentiation antigens. J Biol Chem (1988) 1.96
Purification and characterization of human lysosomal membrane glycoproteins. Arch Biochem Biophys (1989) 1.90
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma. J Natl Cancer Inst (2000) 1.81
Aromatic-degrading Sphingomonas isolates from the deep subsurface. Appl Environ Microbiol (1995) 1.79
Endoscopic ultrasonography-guided fine-needle aspiration biopsy of suspected pancreatic cancer. Ann Intern Med (2001) 1.68
Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells. J Natl Cancer Inst (1997) 1.63
Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med (1979) 1.61
The motif Tyr-X-X-hydrophobic residue mediates lysosomal membrane targeting of lysosome-associated membrane protein 1. J Biol Chem (1993) 1.58
A temperature-sensitive mutant of human p53. EMBO J (1994) 1.51
Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood (1995) 1.45
Triple-tissue sampling at ERCP in malignant biliary obstruction. Gastrointest Endosc (2000) 1.42
Taxonomic study of aromatic-degrading bacteria from deep-terrestrial-subsurface sediments and description of Sphingomonas aromaticivorans sp. nov., Sphingomonas subterranea sp. nov., and Sphingomonas stygia sp. nov. Int J Syst Bacteriol (1997) 1.41
p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res (1995) 1.40
Sjögren-type syndrome after allogeneic bone-marrow transplantation. Ann Intern Med (1977) 1.27
Interaction of nuclear proteins with an AP-1/CRE-like promoter sequence in the human TNF-alpha gene. J Leukoc Biol (1994) 1.24
Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med (1981) 1.21
The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer. J Thromb Haemost (2009) 1.18
Development of chemotactic responsiveness in myeloid precursor cells: studies with a human leukemia cell line. Proc Natl Acad Sci U S A (1980) 1.17
Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res (1996) 1.17
Novel DNA binding of p53 mutants and their role in transcriptional activation. Oncogene (1993) 1.16
Scleroderma, Sjögren-like syndrome, and chronic graft-versus-host disease. Ann Intern Med (1977) 1.14
Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. Blood (1994) 1.12
Oxygen-dependent autoaggregation in Shewanella oneidensis MR-1. Environ Microbiol (2008) 1.11
Homology between genes for aromatic hydrocarbon degradation in surface and deep-subsurface Sphingomonas strains. Appl Environ Microbiol (1996) 1.11
Lymphocyte depletion by continuous flow cell centrifugation in rheumatoid arthritis: clinical effects. Arthritis Rheum (1979) 1.10
Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit. Gene Ther (1995) 1.08
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation. Blood (1996) 1.08
Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood (1978) 1.07
Treatment of poor prognosis nonseminomatous testicular cancer with a "high-dose" platinum combination chemotherapy regimen. Cancer (1983) 1.06
High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia. Clin Cancer Res (1995) 1.06
Artificial cranial deformation and the increased complexity of the lambdoid suture. Am J Phys Anthropol (1978) 1.05
Median arcuate ligament syndrome with multivessel involvement: diagnosis with spiral CT angiography. Abdom Imaging (1997) 1.05
Endoscopic ultrasound characteristics of mucinous cystic neoplasms of the pancreas. Am J Gastroenterol (2000) 1.03
Hyperphosphorylation of p53 induced by okadaic acid attenuates its transcriptional activation function. Cancer Res (1994) 1.03
Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood (1992) 1.03
A prospective evaluation of the incidence of bacteremia associated with EUS-guided fine-needle aspiration. Gastrointest Endosc (2001) 1.02
Halomonas campisalis sp. nov., a denitrifying, moderately haloalkaliphilic bacterium. Syst Appl Microbiol (1999) 1.01
Role of internal thermodynamics in determining hydrogen tunneling in enzyme-catalyzed hydrogen transfer reactions. Biochemistry (1992) 1.00
Ecology, physiology, and phylogeny of deep subsurface Sphingomonas sp. J Ind Microbiol Biotechnol (1999) 0.99
Result of attempted hematopoietic reconstitution using isologous, peripheral blood mononuclear cells: a case report. Blood (1980) 0.98
High efficiency gene transfection by electroporation using a radio-frequency electric field. Biochim Biophys Acta (1991) 0.97
Loss of imprinting in disease progression in chronic myelogenous leukemia. Blood (1998) 0.97
Electrokinesis is a microbial behavior that requires extracellular electron transport. Proc Natl Acad Sci U S A (2009) 0.97
Cyclophosphamide treatment expands the circulating hematopoietic stem cell pool in dogs. J Clin Invest (1981) 0.97
Physical mapping and characterization of a catabolic plasmid from the deep-subsurface bacterium Sphingomonas sp. strain F199. J Bacteriol (1995) 0.96
Human interferon regulatory factor 2 gene. Intron-exon organization and functional analysis of 5'-flanking region. J Biol Chem (1994) 0.95
Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells. J Clin Invest (1991) 0.95
Monoclonal antibody phenotyping of interindividual differences in cytochrome P-450-dependent reactions of single and twin human placenta. Cancer Res (1984) 0.95
Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood (1994) 0.94
Effects of meperidine on the pancreatic and biliary sphincter. Gastrointest Endosc (1996) 0.93
Identification of a population of bipotent stem cells in the HL60 human promyelocytic leukemia cell line. Proc Natl Acad Sci U S A (1981) 0.93
Endoscopic lithotripsy of bile duct stones using a new laser with automatic stone recognition. Gastrointest Endosc (1995) 0.92
Study of cell dose and storage time on engraftment of cryopreserved autologous bone marrow in a canine model. Transplantation (1978) 0.92
Lymphocyte depletion and immunosuppression with repeated leukapheresis by continuous flow centrifugation. Blood (1981) 0.92
Difficult sigmoid colon intubation: guide wire exchange technique. Gastrointest Endosc (1996) 0.91
Peptide containing the BCR oligomerization domain (AA 1-160) reverses the transformed phenotype of p210bcr-abl positive 32D myeloid leukemia cells. Oncogene (1998) 0.90
Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy. Proc Natl Acad Sci U S A (1996) 0.89
Suppression of transfusion-related alloimmunization in intensively treated cancer patients. Blood (1981) 0.89
Burkitt's lymphoma--a model for intensive chemotherapy. Semin Oncol (1977) 0.89
Activation of p21WAF1/Cip1 expression by a temperature-sensitive mutant of human p53 does not lead to apoptosis. Oncogene (1995) 0.89
Amplification of circulating granulocyte-monocyte stem cell numbers following chemotherapy in patients with extensive small cell carcinoma of the lung. Cancer Res (1981) 0.89
Cisplatin dose intensity in non-small cell lung cancer: phase II results of a day 1 and day 8 high-dose regimen. J Natl Cancer Inst (1989) 0.88
Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model. Cancer Gene Ther (1994) 0.88
Recent advances in the application of gene therapy to human disease. Am J Med (1995) 0.88
Donor toxicity in granulocyte collections: association of lichen planus with the use of hydroxyethyl starch leukapheresis. Transfusion (1981) 0.88
P53 gene mutations in acute myelogenous leukaemia. Br J Haematol (1992) 0.88
Gastrostomy tube deterioration and fungal colonization. Am J Gastroenterol (1992) 0.87
Expression of unusual immunophenotype combinations in acute myelogenous leukemia. Blood (1993) 0.87
Rescue from apoptosis in early (CD34-selected) versus late (non-CD34-selected) human hematopoietic cells by very late antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cells. Cell Growth Differ (1998) 0.87
Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology. Am J Med (1996) 0.87
Acanthamoeba meningoencephalitis after bone marrow transplantation. Bone Marrow Transplant (1994) 0.86
Microbial genomics: the floodgates open. Trends Microbiol (1997) 0.86
Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia. Bone Marrow Transplant (1999) 0.86
Successful continuation of cisplatin therapy after partial recovery from acute renal failure. Cancer Treat Rep (1985) 0.86
Haemopoietic recovery in Ewing's sarcoma after intensive combination therapy and autologous marrow infusion. Lancet (1980) 0.86
Use of the cosmid adenoviral vector cloning system for the in vitro construction of recombinant adenoviral vectors. Hum Gene Ther (1997) 0.86
Therapeutic biliary endoscopy. Endoscopy (1998) 0.86
Mobilization and exocytosis of specific (secondary) granules by human neutrophils during adherence to nylon wood in filtration leukapheresis (FL). Blood (1978) 0.85
PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells. Clin Cancer Res (1995) 0.84
Human gene marker/therapy clinical protocols. Hum Gene Ther (2000) 0.84
Surgical hypothermia in a patient with a cold agglutinin. Management by plasma exchange. Transfusion (1980) 0.84
Proliferating cell nuclear antigen (PCNA) expression in chronic lymphocytic leukemia (CLL). Leuk Lymphoma (1993) 0.83
Hematopoietic retroviral gene marking in patients with follicular non-Hodgkin's lymphoma. Leuk Lymphoma (1999) 0.83
High and low levels of cottontail rabbit papillomavirus E2 protein generate opposite effects on gene expression. J Biol Chem (2001) 0.83
Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse. Cancer (1978) 0.83
Acquired alpha-thalassemia in preleukemia is due to decreased expression of all four alpha-globin genes. Proc Natl Acad Sci U S A (1983) 0.82
Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomas. Leuk Lymphoma (1996) 0.82
Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer. J Clin Oncol (1986) 0.82
Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Cancer Gene Ther (1995) 0.81
Development of a sensitive PCR to detect allele loss in a model hematopoietic neoplasm. PCR Methods Appl (1994) 0.81
Combinatorial chemistry in cancer drug development. Cancer J (2001) 0.81
5q- chromosome. Evidence for complex interstitial breaks in a case of refractory anemia with excess blasts. Cancer Genet Cytogenet (1994) 0.81